<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02629432</url>
  </required_header>
  <id_info>
    <org_study_id>01GI0884</org_study_id>
    <nct_id>NCT02629432</nct_id>
  </id_info>
  <brief_title>Image-Based Structural and Functional Phenotyping of the COSYCONET Cohort Using MRI and CT</brief_title>
  <acronym>MR-COPD</acronym>
  <official_title>Image-Based Structural and Functional Phenotyping of the COSYCONET Cohort Using MRI and CT (MR COPD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Heidelberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Philipps University Marburg Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hannover Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Heidelberg</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this trial is to prove that MRI - as the imaging modality without the
      use of ionizing radiation - can replace CT for structural and functional regional phenotyping
      of COPD. The identification of different COPD phenotypes, such as the &quot;emphysema-type&quot; and
      the &quot;airway-type&quot;, is important because therapy and prognosis will be different. The medical
      problem addressed in this trial is the image-based phenotyping of COPD. The sensitivity and
      specificity of MRI will be compared to Lowdose-CT serving as the gold standard. MRI and CT of
      the lung will be performed in a multi-centre cohort of 625 COPD-patients from the main
      COSYCONET cohort. The reliability of the MRI results will be demonstrated. MRI phenotypes
      will be evaluated visually and using software with quantitative read-outs. The agreement of
      both will be determined. The additional information of MRI over CT will be assessed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective trial aims to phenotype COPD by using Imaging methods.The identification of
      different COPD phenotypes, such as the &quot;emphysema-type&quot; and the &quot;airway-type&quot;, is important
      because therapy and prognosis will be different. Imaging might play a central role in
      diagnosing these phenotypes. So far computed tomography (CT) is regarded as the gold
      standard, but it involves ionizing radiation and lacks functional information. The medical
      problem addressed in this trial is the image-based phenotyping of COPD. The principal
      research question is whether magnetic resonance imaging (MRI) can replace CT for the
      characterization of COPD by &quot;structural and functional phenotyping&quot; on a regional basis. The
      sensitivity and specificity of MRI will be compared to CT serving as the gold standard. To
      achieve this goal, MRI and CT of the lung will be performed in a multi-centre cohort of 625
      COPD-patients from the main Cosyconet cohort. Also, the reliability of the MRI results will
      be demonstrated. MRI phenotypes will be evaluated visually and using software with
      quantitative read-outs. The agreement of both will be determined. The additional information
      of MRI over CT will be assessed. A special focus will be to implement an image-based
      biomarker of pulmonary functional reserve derived from the MRI measurement of pulmonary
      perfusion, which will be correlated with results from pulmonary functions tests (e.g. the
      lung transfer factor for carbon monoxide (TLCO)) the 6-minute walking test (6-MWD), and
      extrapulmonary disease manifestations.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Sensitivity and specificity of MRI for the diagnosis of emphysema-predominant vs. airway-predominant COPD phenotype based on semi-quantitative visual image evaluation with CT as standard of reference</measure>
    <time_frame>single time point/baseline only</time_frame>
    <description>diagnostic study, MRI and CT acquired on the same day</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of completed examinations with diagnostic image quality to determine the achievable diagnostic quality of lung MRI in a multi-center setting</measure>
    <time_frame>single time point/baseline only</time_frame>
    <description>to assess the achievable image quality in a multicentre setting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>agreement of visual and software-based phenotyping on MRI and CT (airway wall thickening, air trapping, emphysema, lung perfusion deficits)</measure>
    <time_frame>single time point/baseline only</time_frame>
    <description>to compare both modalities for the assessment of those parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>correlation of MRI metrics with clinical tests: predictive value of perfusion MRI for pulmonary functional reserve compared to clinical tests, i.e. pulmonary function tests (TLCO) and six-minute walk test (6 MWT)</measure>
    <time_frame>single time point/baseline only</time_frame>
    <description>to assess the value of MRI-based biomarkers in comparison to clinical data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of cases in which MRI (i.e. functional parameters) produces clinically relevant additional information to CT</measure>
    <time_frame>single time point/baseline only</time_frame>
    <description>to assess potential advantages of MR compared to CT</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">602</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease (COPD)</condition>
  <arm_group>
    <arm_group_label>Cosyconet COPD Cohort</arm_group_label>
    <description>MRI and CT of the lung will be performed in a multi-centre cohort of 625 COPD-patients from the main COSYCONET cohort.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        This Trial is fully embedded within the main cohort of the Cosyconet-Study: Impact of
        Systemic Manifestations/Comorbidities on Clinical State, Prognosis, Utilisation of Health
        care Ressources in Patients with COPD (COSYCONET), NCT01245933 ). Only patients included
        into the main study are asked to take part in this sub-trial which is not pharmaceutical
        and only has one arm including the expected number of patients (625) .
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The population to be studied is determined by the main Cosyconet-cohort.

        Key inclusion criteria:

          -  being included into the main cohort

          -  diagnosis of COPD (GOLD criteria)

          -  availability for repeated study visits

          -  male or female

          -  age &gt; 40 years

        Exclusion Criteria:

          -  Key exclusion criteria as determined by the main Cosyconet-cohort:

          -  having undergone lung surgery (e.g., lung volume reduction, lung transplant)

          -  moderate or severe exacerbation within the last 4 weeks prior to visit 1

          -  unable to understand the intention of the project

          -  lack of signed patient informed consent

          -  contraindications for MRI

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juergen Biederer, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Heidelberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bertram Jobst, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Heidelberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitätsklinikum, Diagnostische und Interventionelle Radiologie und Neuroradiologie</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Gießen und Marburg GmbH,Klinik für Diagnostische und Interventionelle Radiologie</name>
      <address>
        <city>Giessen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Greifswald, Institut für Diagnostische Radiologie u. Neuroradiologie</name>
      <address>
        <city>Greifswald</city>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LungenClinic Grosshansdorf, Pneumologisches Forschungsinstitut</name>
      <address>
        <city>Grosshansdorf</city>
        <zip>22927</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hamburger Institut für Therapieforschung (HIT) GmbH</name>
      <address>
        <city>Hamburg</city>
        <zip>20354</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover, Zentrum Radiologie, Institut für Diagnostische und Interventionelle Radiologie</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg, Diagnostische und Interventionelle Radiologie</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thoraxklinik Heidelberg, Diagnostische und Interventionelle Radiologie</name>
      <address>
        <city>Heidelberg</city>
        <zip>69126</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum des Saarlandes, Klinik für Diagnostische und Interventionelle Radiologie</name>
      <address>
        <city>Homburg</city>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Schleswig Holstein, Klinik für Diagnostische Radiologie, Campus Kiel</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Leipzig, Department für Bildgebung und Strahlenmedizin</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum, Zentrum für Radiologie, Klinik für Diagnostische und Interventionelle Radiologie</name>
      <address>
        <city>Marburg</city>
        <zip>35043</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institut für Klinische Radiologie, Klinikum der Universität Muenchen (KUM), Campus Innenstadt Muenchen</name>
      <address>
        <city>Muenchen</city>
        <zip>80336</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität Muenchen, Institut für Klinische Radiologie</name>
      <address>
        <city>Muenchen</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Nord-Nuernberg, Radiologie</name>
      <address>
        <city>Nuernberg</city>
        <zip>90419</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Biederer J, Mirsadraee S, Beer M, Molinari F, Hintze C, Bauman G, Both M, Van Beek EJ, Wild J, Puderbach M. MRI of the lung (3/3)-current applications and future perspectives. Insights Imaging. 2012 Aug;3(4):373-86. doi: 10.1007/s13244-011-0142-z. Epub 2012 Jan 15.</citation>
    <PMID>22695943</PMID>
  </reference>
  <reference>
    <citation>Biederer J, Beer M, Hirsch W, Wild J, Fabel M, Puderbach M, Van Beek EJ. MRI of the lung (2/3). Why … when … how? Insights Imaging. 2012 Aug;3(4):355-71. doi: 10.1007/s13244-011-0146-8. Epub 2012 Feb 13.</citation>
    <PMID>22695944</PMID>
  </reference>
  <reference>
    <citation>Wild JM, Marshall H, Bock M, Schad LR, Jakob PM, Puderbach M, Molinari F, Van Beek EJ, Biederer J. MRI of the lung (1/3): methods. Insights Imaging. 2012 Aug;3(4):345-53. doi: 10.1007/s13244-012-0176-x. Epub 2012 Jun 13.</citation>
    <PMID>22695952</PMID>
  </reference>
  <reference>
    <citation>Eichinger M, Optazaite DE, Kopp-Schneider A, Hintze C, Biederer J, Niemann A, Mall MA, Wielpütz MO, Kauczor HU, Puderbach M. Morphologic and functional scoring of cystic fibrosis lung disease using MRI. Eur J Radiol. 2012 Jun;81(6):1321-9. doi: 10.1016/j.ejrad.2011.02.045. Epub 2011 Mar 23.</citation>
    <PMID>21429685</PMID>
  </reference>
  <reference>
    <citation>COPDGene CT Workshop Group, Barr RG, Berkowitz EA, Bigazzi F, Bode F, Bon J, Bowler RP, Chiles C, Crapo JD, Criner GJ, Curtis JL, Dass C, Dirksen A, Dransfield MT, Edula G, Erikkson L, Friedlander A, Galperin-Aizenberg M, Gefter WB, Gierada DS, Grenier PA, Goldin J, Han MK, Hanania NA, Hansel NN, Jacobson FL, Kauczor HU, Kinnula VL, Lipson DA, Lynch DA, MacNee W, Make BJ, Mamary AJ, Mann H, Marchetti N, Mascalchi M, McLennan G, Murphy JR, Naidich D, Nath H, Newell JD Jr, Pistolesi M, Regan EA, Reilly JJ, Sandhaus R, Schroeder JD, Sciurba F, Shaker S, Sharafkhaneh A, Silverman EK, Steiner RM, Strange C, Sverzellati N, Tashjian JH, van Beek EJ, Washington L, Washko GR, Westney G, Wood SA, Woodruff PG. A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD. 2012 Apr;9(2):151-9. doi: 10.3109/15412555.2012.654923. Epub 2012 Mar 19.</citation>
    <PMID>22429093</PMID>
  </reference>
  <reference>
    <citation>Gietema HA, Müller NL, Fauerbach PV, Sharma S, Edwards LD, Camp PG, Coxson HO; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Quantifying the extent of emphysema: factors associated with radiologists' estimations and quantitative indices of emphysema severity using the ECLIPSE cohort. Acad Radiol. 2011 Jun;18(6):661-71. doi: 10.1016/j.acra.2011.01.011. Epub 2011 Mar 9.</citation>
    <PMID>21393027</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 23, 2015</study_first_submitted>
  <study_first_submitted_qc>December 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2015</study_first_posted>
  <last_update_submitted>May 10, 2017</last_update_submitted>
  <last_update_submitted_qc>May 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Heidelberg</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Juergen Biederer</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <keyword>MRI</keyword>
  <keyword>COPD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Pseudonymized Data from structured image reads will be transferred to the central COSYCONET data bank in Hannover. Application form for project proposals and data retrieval can be downloaded here: http://www.asconet.net/html/cosyconet/projects?clps4835_49326291=1</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

